ASHLEY GONIEA: Open Payments
NPI 1871009456 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 65 payments from 18 companies in 2025. Trend: 2023 $161 · 2024 $511 · 2025 $1,248
Food & beverage: $1,248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| Lilly USA, LLC | 11 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $187 |
| PFIZER INC. | 5 | $104 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Phathom Pharmaceuticals, Inc. | 4 | $76 |
| Novo Nordisk Inc | 3 | $70 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Amgen Inc. | 3 | $42 |
Products named: CAPLYTA, VRAYLAR, JARDIANCE, Auvelity, REXULTI, VOQUEZNA, Ozempic, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
